Blue Water Life Science Advisors’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-603,937
| Closed | -$2.37M | – | 9 |
|
|
2024
Q2 | $2.37M | Hold |
603,937
| – | – | 2.3% | 8 |
|
|
2024
Q1 | $2.53M | Sell |
603,937
-1,281,063
| -68% | -$5.37M | 2.38% | 8 |
|
|
2023
Q4 | $8.86M | Hold |
1,885,000
| – | – | 7.76% | 6 |
|
|
2023
Q3 | $5.88M | Hold |
1,885,000
| – | – | 5.55% | 6 |
|
|
2023
Q2 | $8.65M | Sell |
1,885,000
-1,340,000
| -42% | -$6.15M | 5.84% | 6 |
|
|
2023
Q1 | $16M | Hold |
3,225,000
| – | – | 10.56% | 4 |
|
|
2022
Q4 | $17.6M | Hold |
3,225,000
| – | – | 11.83% | 5 |
|
|
2022
Q3 | $21M | Buy |
+3,225,000
| New | +$21M | 8.46% | 7 |
|